ArticleCancer immunology, immunotherapy : CII2017

The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity.

Fiona C Thistlethwaite et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.